Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 66 entries
Sorted by: Best Match Show Resources per page
DIVERGENCE IN CACTOPHILIC DROSOPHILA: THE EVOLUTIONARY SIGNIFICANCE OF ADULT ETHANOL METABOLISM.

Evolution; international journal of organic evolution

Etges WJ.
PMID: 28564501
Evolution. 1989 Sep;43(6):1316-1319. doi: 10.1111/j.1558-5646.1989.tb02579.x.

No abstract available.

Cite
Etges WJ. DIVERGENCE IN CACTOPHILIC DROSOPHILA: THE EVOLUTIONARY SIGNIFICANCE OF ADULT ETHANOL METABOLISM. Evolution. 1989;43(6):1316-1319doi: 10.1111/j.1558-5646.1989.tb02579.x.
Etges, W. J. (1989). DIVERGENCE IN CACTOPHILIC DROSOPHILA: THE EVOLUTIONARY SIGNIFICANCE OF ADULT ETHANOL METABOLISM. Evolution; international journal of organic evolution, 43(6), 1316-1319. https://doi.org/10.1111/j.1558-5646.1989.tb02579.x
Etges, William J. "DIVERGENCE IN CACTOPHILIC DROSOPHILA: THE EVOLUTIONARY SIGNIFICANCE OF ADULT ETHANOL METABOLISM." Evolution; international journal of organic evolution vol. 43,6 (1989): 1316-1319. doi: https://doi.org/10.1111/j.1558-5646.1989.tb02579.x
Etges WJ. DIVERGENCE IN CACTOPHILIC DROSOPHILA: THE EVOLUTIONARY SIGNIFICANCE OF ADULT ETHANOL METABOLISM. Evolution. 1989 Sep;43(6):1316-1319. doi: 10.1111/j.1558-5646.1989.tb02579.x. PMID: 28564501.
Copy Download .nbib Format: NLM
Pain; still an intriguing puzzle.

Social science & medicine (1982)

Menges LJ.
PMID: 6531705
Soc Sci Med. 1984;19(12):1257-60. doi: 10.1016/0277-9536(84)90013-3.

No abstract available.

Cite
Menges LJ. Pain; still an intriguing puzzle. Soc Sci Med. 1984;19(12):1257-60doi: 10.1016/0277-9536(84)90013-3.
Menges, L. J. (1984). Pain; still an intriguing puzzle. Social science & medicine (1982), 19(12), 1257-60. https://doi.org/10.1016/0277-9536(84)90013-3
Menges, L J. "Pain; still an intriguing puzzle." Social science & medicine (1982) vol. 19,12 (1984): 1257-60. doi: https://doi.org/10.1016/0277-9536(84)90013-3
Menges LJ. Pain; still an intriguing puzzle. Soc Sci Med. 1984;19(12):1257-60. doi: 10.1016/0277-9536(84)90013-3. PMID: 6531705.
Copy Download .nbib Format: NLM
Premating isolation is determined by larval rearing substrates in cactophilic Drosophila mojavensis. IV. Correlated responses in behavioral isolation to artificial selection on a life-history trait.

The American naturalist

Etges WJ.
PMID: 18811406
Am Nat. 1998 Jul;152(1):129-44. doi: 10.1086/286154.

Studies of behavioral isolation among geographically isolated populations of Drosophila mojavensis have provided an understanding of incipient speciation wherein phylogeny and ecology play a prominent role. Populations of D. mojavensis in mainland Mexico and southern Arizona exhibit low but...

Cite
Etges WJ. Premating isolation is determined by larval rearing substrates in cactophilic Drosophila mojavensis. IV. Correlated responses in behavioral isolation to artificial selection on a life-history trait. Am Nat. 1998;152(1):129-44doi: 10.1086/286154.
Etges, W. J. (1998). Premating isolation is determined by larval rearing substrates in cactophilic Drosophila mojavensis. IV. Correlated responses in behavioral isolation to artificial selection on a life-history trait. The American naturalist, 152(1), 129-44. https://doi.org/10.1086/286154
Etges, W J. "Premating isolation is determined by larval rearing substrates in cactophilic Drosophila mojavensis. IV. Correlated responses in behavioral isolation to artificial selection on a life-history trait." The American naturalist vol. 152,1 (1998): 129-44. doi: https://doi.org/10.1086/286154
Etges WJ. Premating isolation is determined by larval rearing substrates in cactophilic Drosophila mojavensis. IV. Correlated responses in behavioral isolation to artificial selection on a life-history trait. Am Nat. 1998 Jul;152(1):129-44. doi: 10.1086/286154. PMID: 18811406.
Copy Download .nbib Format: NLM
Premating isolation is determined by larval-rearing substrates in cactophilic Drosophila mojavensis. V. Deep geographic variation in epicuticular hydrocarbons among isolated populations.

The American naturalist

Etges WJ, Ahrens MA.
PMID: 18707353
Am Nat. 2001 Dec;158(6):585-98. doi: 10.1086/323587.

Adult epicuticular hydrocarbon variation of 14 geographically isolated populations of cactophilic Drosophila mojavensis was assessed to further investigate mechanisms of sexual isolation. Hydrocarbon transfer experiments demonstrated that these compounds are part of the mate recognition system in this species....

Cite
Etges WJ, Ahrens MA. Premating isolation is determined by larval-rearing substrates in cactophilic Drosophila mojavensis. V. Deep geographic variation in epicuticular hydrocarbons among isolated populations. Am Nat. 2001;158(6):585-98doi: 10.1086/323587.
Etges, W. J., & Ahrens, M. A. (2001). Premating isolation is determined by larval-rearing substrates in cactophilic Drosophila mojavensis. V. Deep geographic variation in epicuticular hydrocarbons among isolated populations. The American naturalist, 158(6), 585-98. https://doi.org/10.1086/323587
Etges, W J, and Ahrens, M A. "Premating isolation is determined by larval-rearing substrates in cactophilic Drosophila mojavensis. V. Deep geographic variation in epicuticular hydrocarbons among isolated populations." The American naturalist vol. 158,6 (2001): 585-98. doi: https://doi.org/10.1086/323587
Etges WJ, Ahrens MA. Premating isolation is determined by larval-rearing substrates in cactophilic Drosophila mojavensis. V. Deep geographic variation in epicuticular hydrocarbons among isolated populations. Am Nat. 2001 Dec;158(6):585-98. doi: 10.1086/323587. PMID: 18707353.
Copy Download .nbib Format: NLM
What comes after producing the evidence? The importance of external validity to translating science to practice.

Clinical therapeutics

Metge CJ.
PMID: 21665042
Clin Ther. 2011 May;33(5):578-80. doi: 10.1016/j.clinthera.2011.05.050.

No abstract available.

Cite
Metge CJ. What comes after producing the evidence? The importance of external validity to translating science to practice. Clin Ther. 2011;33(5):578-80doi: 10.1016/j.clinthera.2011.05.050.
Metge, C. J. (2011). What comes after producing the evidence? The importance of external validity to translating science to practice. Clinical therapeutics, 33(5), 578-80. https://doi.org/10.1016/j.clinthera.2011.05.050
Metge, Colleen J. "What comes after producing the evidence? The importance of external validity to translating science to practice." Clinical therapeutics vol. 33,5 (2011): 578-80. doi: https://doi.org/10.1016/j.clinthera.2011.05.050
Metge CJ. What comes after producing the evidence? The importance of external validity to translating science to practice. Clin Ther. 2011 May;33(5):578-80. doi: 10.1016/j.clinthera.2011.05.050. PMID: 21665042.
Copy Download .nbib Format: NLM
Comparative observations on growth rate and reproduction of Australorbis glabratus in field and laboratory conditions.

Bulletin of the World Health Organization

Etges FJ, Ritchie LS.
PMID: 20604209
Bull World Health Organ. 1966;34(6):963-6.

No abstract available.

Cite
Etges FJ, Ritchie LS. Comparative observations on growth rate and reproduction of Australorbis glabratus in field and laboratory conditions. Bull World Health Organ. 1966;34(6):963-6
Etges, F. J., & Ritchie, L. S. (1966). Comparative observations on growth rate and reproduction of Australorbis glabratus in field and laboratory conditions. Bulletin of the World Health Organization, 34(6), 963-6.
Etges, F J, and Ritchie, L S. "Comparative observations on growth rate and reproduction of Australorbis glabratus in field and laboratory conditions." Bulletin of the World Health Organization vol. 34,6 (1966): 963-6.
Etges FJ, Ritchie LS. Comparative observations on growth rate and reproduction of Australorbis glabratus in field and laboratory conditions. Bull World Health Organ. 1966;34(6):963-6. PMID: 20604209; PMCID: PMC2476052.
Copy Download .nbib Format: NLM
Storage of Nuclear Excitation Energy through Magnetic Switching.

Physical review letters

Gerdau E, Hertrich T, Leupold O, Metge J, Potzel W, Rüter HD, Schindelmann P, Schwendy S, Shvyd'ko YV, Smirnov GV, van Bürck U.
PMID: 10062167
Phys Rev Lett. 1996 Oct 07;77(15):3232-3235. doi: 10.1103/PhysRevLett.77.3232.

No abstract available.

Cite
Gerdau E, Hertrich T, Leupold O, et al. Storage of Nuclear Excitation Energy through Magnetic Switching. Phys Rev Lett. 1996;77(15):3232-3235doi: 10.1103/PhysRevLett.77.3232.
Gerdau, E., Hertrich, T., Leupold, O., Metge, J., Potzel, W., Rüter, H. D., Schindelmann, P., Schwendy, S., Shvyd'ko, Y. V., Smirnov, G. V., & van Bürck U. (1996). Storage of Nuclear Excitation Energy through Magnetic Switching. Physical review letters, 77(15), 3232-3235. https://doi.org/10.1103/PhysRevLett.77.3232
Gerdau, et al. "Storage of Nuclear Excitation Energy through Magnetic Switching." Physical review letters vol. 77,15 (1996): 3232-3235. doi: https://doi.org/10.1103/PhysRevLett.77.3232
Gerdau E, Hertrich T, Leupold O, Metge J, Potzel W, Rüter HD, Schindelmann P, Schwendy S, Shvyd'ko YV, Smirnov GV, van Bürck U. Storage of Nuclear Excitation Energy through Magnetic Switching. Phys Rev Lett. 1996 Oct 07;77(15):3232-3235. doi: 10.1103/PhysRevLett.77.3232. PMID: 10062167.
Copy Download .nbib Format: NLM
Inhibition of Hedgehog signaling reprograms the dysfunctional immune microenvironment in breast cancer.

Oncoimmunology

Hanna A, Metge BJ, Bailey SK, Chen D, Chandrashekar DS, Varambally S, Samant RS, Shevde LA.
PMID: 30723576
Oncoimmunology. 2018 Dec 12;8(3):1548241. doi: 10.1080/2162402X.2018.1548241. eCollection 2019.

Host responses to tumor cells include tumor suppressing or promoting mechanisms. We sought to detail the effect of Hedgehog (Hh) pathway inhibition on the composition of the mammary tumor immune portfolio. We hypothesized that Hh signaling mediates a crosstalk...

Cite
Hanna A, Metge BJ, Bailey SK, et al. Inhibition of Hedgehog signaling reprograms the dysfunctional immune microenvironment in breast cancer. Oncoimmunology. 2018;8(3):1548241doi: 10.1080/2162402X.2018.1548241.
Hanna, A., Metge, B. J., Bailey, S. K., Chen, D., Chandrashekar, D. S., Varambally, S., Samant, R. S., & Shevde, L. A. (2019). Inhibition of Hedgehog signaling reprograms the dysfunctional immune microenvironment in breast cancer. Oncoimmunology, 8(3), 1548241. https://doi.org/10.1080/2162402X.2018.1548241
Hanna, Ann, et al. "Inhibition of Hedgehog signaling reprograms the dysfunctional immune microenvironment in breast cancer." Oncoimmunology vol. 8,3 (2019): 1548241. doi: https://doi.org/10.1080/2162402X.2018.1548241
Hanna A, Metge BJ, Bailey SK, Chen D, Chandrashekar DS, Varambally S, Samant RS, Shevde LA. Inhibition of Hedgehog signaling reprograms the dysfunctional immune microenvironment in breast cancer. Oncoimmunology. 2018 Dec 12;8(3):1548241. doi: 10.1080/2162402X.2018.1548241. eCollection 2019. PMID: 30723576; PMCID: PMC6350695.
Copy Download .nbib Format: NLM
An extract from the Atlantic brown algae .

Oncotarget

Huebbe P, Nikolai S, Schloesser A, Herebian D, Campbell G, Glüer CC, Zeyner A, Demetrowitsch T, Schwarz K, Metges CC, Roeder T, Schultheiss G, Ipharraguerre IR, Rimbach G.
PMID: 29088722
Oncotarget. 2017 May 23;8(43):73501-73515. doi: 10.18632/oncotarget.18113. eCollection 2017 Sep 26.

In this study we addressed the questions whether an Atlantic brown algae extract (BAE) affects diet induced obesity in mice and which would be the primary targets and underlying key mechanisms. Male C57 BL/6 mice were fed a hypercaloric...

Cite
Huebbe P, Nikolai S, Schloesser A, et al. An extract from the Atlantic brown algae . Oncotarget. 2017;8(43):73501-73515doi: 10.18632/oncotarget.18113.
Huebbe, P., Nikolai, S., Schloesser, A., Herebian, D., Campbell, G., Glüer, C. C., Zeyner, A., Demetrowitsch, T., Schwarz, K., Metges, C. C., Roeder, T., Schultheiss, G., Ipharraguerre, I. R., & Rimbach, G. (2017). An extract from the Atlantic brown algae . Oncotarget, 8(43), 73501-73515. https://doi.org/10.18632/oncotarget.18113
Huebbe, Patricia, et al. "An extract from the Atlantic brown algae ." Oncotarget vol. 8,43 (2017): 73501-73515. doi: https://doi.org/10.18632/oncotarget.18113
Huebbe P, Nikolai S, Schloesser A, Herebian D, Campbell G, Glüer CC, Zeyner A, Demetrowitsch T, Schwarz K, Metges CC, Roeder T, Schultheiss G, Ipharraguerre IR, Rimbach G. An extract from the Atlantic brown algae . Oncotarget. 2017 May 23;8(43):73501-73515. doi: 10.18632/oncotarget.18113. eCollection 2017 Sep 26. PMID: 29088722; PMCID: PMC5650277.
Copy Download .nbib Format: NLM
The relationship between methane emission and daytime-dependent fecal archaeol concentration in lactating dairy cows fed two different diets.

Archives animal breeding

Sandberg LM, Thaller G, Görs S, Kuhla B, Metges CC, Krattenmacher N.
PMID: 32760788
Arch Anim Breed. 2020 Jul 02;63(2):211-218. doi: 10.5194/aab-63-211-2020. eCollection 2020.

Archaeol is a cell membrane lipid of methanogenic archaea excreted in feces and is therefore a potential biomarker for individual methane emission (MEM). The aims of this study were to examine the potential of the fecal archaeol concentration (fArch)...

Cite
Sandberg LM, Thaller G, Görs S, et al. The relationship between methane emission and daytime-dependent fecal archaeol concentration in lactating dairy cows fed two different diets. Arch Anim Breed. 2020;63(2):211-218doi: 10.5194/aab-63-211-2020.
Sandberg, L. M., Thaller, G., Görs, S., Kuhla, B., Metges, C. C., & Krattenmacher, N. (2020). The relationship between methane emission and daytime-dependent fecal archaeol concentration in lactating dairy cows fed two different diets. Archives animal breeding, 63(2), 211-218. https://doi.org/10.5194/aab-63-211-2020
Sandberg, Lisa-Marie, et al. "The relationship between methane emission and daytime-dependent fecal archaeol concentration in lactating dairy cows fed two different diets." Archives animal breeding vol. 63,2 (2020): 211-218. doi: https://doi.org/10.5194/aab-63-211-2020
Sandberg LM, Thaller G, Görs S, Kuhla B, Metges CC, Krattenmacher N. The relationship between methane emission and daytime-dependent fecal archaeol concentration in lactating dairy cows fed two different diets. Arch Anim Breed. 2020 Jul 02;63(2):211-218. doi: 10.5194/aab-63-211-2020. eCollection 2020. PMID: 32760788; PMCID: PMC7397718.
Copy Download .nbib Format: NLM
Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival.

Journal for immunotherapy of cancer

Shah MA, Cunningham D, Metges JP, Van Cutsem E, Wainberg Z, Elboudwarej E, Lin KW, Turner S, Zavodovskaya M, Inzunza D, Liu J, Patterson SD, Zhou J, He J, Thai D, Bhargava P, Brachmann CB, Cantenacci DVT.
PMID: 34893523
J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-003580.

BACKGROUND: Matrix metalloproteinase-9 (MMP9) selectively cleaves extracellular matrix proteins contributing to tumor growth and an immunosuppressive microenvironment. This study evaluated andecaliximab (ADX), an inhibitor of MMP9, in combination with nivolumab (NIVO), for the treatment of advanced gastric cancer.METHODS: Phase...

Cite
Shah MA, Cunningham D, Metges JP, et al. Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival. J Immunother Cancer. 2021;9(12)doi: 10.1136/jitc-2021-003580.
Shah, M. A., Cunningham, D., Metges, J. P., Van Cutsem, E., Wainberg, Z., Elboudwarej, E., Lin, K. W., Turner, S., Zavodovskaya, M., Inzunza, D., Liu, J., Patterson, S. D., Zhou, J., He, J., Thai, D., Bhargava, P., Brachmann, C. B., & Cantenacci, D. V. T. (2021). Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival. Journal for immunotherapy of cancer, 9(12), . https://doi.org/10.1136/jitc-2021-003580
Shah, Manish A, et al. "Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival." Journal for immunotherapy of cancer vol. 9,12 (2021). doi: https://doi.org/10.1136/jitc-2021-003580
Shah MA, Cunningham D, Metges JP, Van Cutsem E, Wainberg Z, Elboudwarej E, Lin KW, Turner S, Zavodovskaya M, Inzunza D, Liu J, Patterson SD, Zhou J, He J, Thai D, Bhargava P, Brachmann CB, Cantenacci DVT. Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival. J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-003580. PMID: 34893523.
Copy Download .nbib Format: NLM
Regorafenib-avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial.

European journal of cancer (Oxford, England : 1990)

Cousin S, Cantarel C, Guegan JP, Mazard T, Gomez-Roca C, Metges JP, Bellera C, Adenis A, Korakis I, Poureau PG, Bourcier K, Toulmonde M, Kind M, Rey C, Auzanneau C, Bessede A, Soubeyran I, Italiano A.
PMID: 34998048
Eur J Cancer. 2022 Jan 05;162:161-169. doi: 10.1016/j.ejca.2021.11.012. Epub 2022 Jan 05.

BACKGROUND: Regorafenib has shown substantial clinical activity in patients with advanced biliary tract cancers (BTCs). Preclinical data suggested that this drug modulates antitumour immunity and is synergistic with immune checkpoint inhibition.PATIENTS AND METHODS: This is a single-arm, multicentric phase...

Cite
Cousin S, Cantarel C, Guegan JP, et al. Regorafenib-avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial. Eur J Cancer. 2022;162:161-169doi: 10.1016/j.ejca.2021.11.012.
Cousin, S., Cantarel, C., Guegan, J. P., Mazard, T., Gomez-Roca, C., Metges, J. P., Bellera, C., Adenis, A., Korakis, I., Poureau, P. G., Bourcier, K., Toulmonde, M., Kind, M., Rey, C., Auzanneau, C., Bessede, A., Soubeyran, I., & Italiano, A. (2022). Regorafenib-avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial. European journal of cancer (Oxford, England : 1990), 162161-169. https://doi.org/10.1016/j.ejca.2021.11.012
Cousin, Sophie, et al. "Regorafenib-avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial." European journal of cancer (Oxford, England : 1990) vol. 162 (2022): 161-169. doi: https://doi.org/10.1016/j.ejca.2021.11.012
Cousin S, Cantarel C, Guegan JP, Mazard T, Gomez-Roca C, Metges JP, Bellera C, Adenis A, Korakis I, Poureau PG, Bourcier K, Toulmonde M, Kind M, Rey C, Auzanneau C, Bessede A, Soubeyran I, Italiano A. Regorafenib-avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial. Eur J Cancer. 2022 Jan 05;162:161-169. doi: 10.1016/j.ejca.2021.11.012. Epub 2022 Jan 05. PMID: 34998048.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 66 entries